巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    G Medical Innovations Holdings Ltd

    GMVD
    0.226
    0.000
    1.80%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・G Medical Innovations Holdings Ltd - 延遲價格・最後更新於 28/09 10:10
    最高位
    0.226
    最低位
    0.226
    開市價
    --
    前收市價
    0.222
    成交量(千)
    0.25
    成交額(百萬)
    0.00
    買入
    0.185
    賣出
    0.275
    每手股數
    --
    市值(百萬)
    6.02
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    5.790 - 0.206
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    G Medical Innovations Holdings Ltd
    證券代碼
    GMVD.US
    所屬板塊
    Medical Instruments & Supplies
    公司業務
    G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
    發行量
    24386680
    公司總部
    5 Oppenheimer Street
    公司網址
    https://www.gmedinnovations.com
    公司電話
    +972 89584777
    暫無內容

    關於

    G Medical Innovations Holdings Ltd(GMVD.US)所屬的行業板塊為Medical Instruments & Supplies。
    G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
    詳細公司背景可參考: https://www.gmedinnovations.com